We are live on ! Find out more
ALBO

Albireo Pharma Inc
ALBO

Delisted

ALBO was delisted on the 2nd of March, 2023.

Back to rankings

74 hedge funds and large institutions have $298M invested in Albireo Pharma Inc in 2019 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 17 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 17

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

9% more capital invested

Capital invested by funds: $273M → $298M (+$25.7M)

3% more funds holding

Funds holding: 72 → 74 (+2)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
74
Holders Change
+2
Holders Change %
+2.78%
% of All Funds
1.61%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
10
Increased
29
Reduced
17
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$24M
2
Man Group
Man Group
United Kingdom
+$5.61M
3
BlackRock
BlackRock
New York
+$2.83M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.63M
5
N
Nuveen
North Carolina
+$1.25M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$4.52M
2
ACH
ArrowMark Colorado Holdings
Colorado
-$3.5M
3
AG
Artal Group
Luxembourg
-$1.67M
4
WMSA
Weiss Multi-Strategy Advisers
New York
-$836K
5
TCM
Tekla Capital Management
Massachusetts
-$664K
Name Holding Trade Value Shares
Change 		Change in
Stake
Allianz Asset Management
26
Allianz Asset Management
Germany
$1.27M +$97.3K +2,908 +8%
BC
27
Birchview Capital
Vermont
$1.23M – – –
N
28
Nuveen
North Carolina
$1.21M +$1.25M +37,449 New
WMSA
29
Weiss Multi-Strategy Advisers
New York
$1.13M -$836K -25,000 -42%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$1.03M -$194K -5,796 -15%
Prudential Financial
31
Prudential Financial
New Jersey
$954K +$1K +30 +0.1%
Deutsche Bank
32
Deutsche Bank
Germany
$841K +$494K +14,761 +130%
AA
33
ALPS Advisors
Colorado
$812K -$124K -3,722 -13%
Charles Schwab
34
Charles Schwab
California
$761K +$105K +3,136 +15%
Two Sigma Investments
35
Two Sigma Investments
New York
$735K +$762K +22,784 New
KCM
36
Kennedy Capital Management
Missouri
$668K +$17.9K +534 +3%
PPA
37
Parametric Portfolio Associates
Washington
$667K -$83.8K -2,505 -11%
Wells Fargo
38
Wells Fargo
California
$585K +$174K +5,192 +40%
EP
39
Eversept Partners
New York
$581K – – –
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$513K +$54.6K +1,633 +11%
JMH
41
J.M. Hartwell
New York
$500K +$41.8K +1,250 +9%
PC
42
PA Capital
Virginia
$466K -$24.6K -736 -5%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$421K +$4.82K +144 +1%
State of Wisconsin Investment Board
44
State of Wisconsin Investment Board
Wisconsin
$406K +$10K +300 +2%
Renaissance Technologies
45
Renaissance Technologies
New York
$330K -$475K -14,200 -58%
New York State Common Retirement Fund
46
New York State Common Retirement Fund
New York
$329K – – –
Squarepoint
47
Squarepoint
New York
$242K +$251K +7,516 New
D.E. Shaw & Co
48
D.E. Shaw & Co
New York
$233K +$242K +7,240 New
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$230K +$238K +7,125 New
Barclays
50
Barclays
United Kingdom
$215K +$133K +3,982 +149%
1
2
3 4

ALBO Hedge Fund Activity: Q2 2019 in Review

74 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q2 2019, worth a combined $298M — up 9.4% from $273M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new ALBO positions and 6 closed out — a net gain of 4 holders — while 29 added to existing stakes and 17 trimmed.

The largest buyer was Federated Hermes, adding an estimated $24M. The largest seller was BVF Inc, cutting an estimated $4.52M.

  • 74 institutional investors held Albireo Pharma Inc (ALBO) as of Q2 2019, up from 72 in Q1 2019.
  • Funds reported $298M of Albireo Pharma Inc stock for Q2 2019, up 9.4% quarter-over-quarter.
  • 10 funds opened new Albireo Pharma Inc positions in Q2 2019 and 6 closed out, a net change of +4 holders.
  • The largest Albireo Pharma Inc buyer in Q2 2019 was Federated Hermes, an estimated $24M added.
  • The largest Albireo Pharma Inc seller in Q2 2019 was BVF Inc, an estimated $4.52M sold.

Based on aggregated 13F filings for Q2 2019.